Changes in PD-L1 Expression Modify IBD-CMF-Mediated Regulation of Tbet and IFN-γ Production by CD3/CD28-Activated and Differentiated Th1 CD4+ T Cells. The gene discussed is CD4; the disease is inflammatory bowel disease.